🗞 Newsmakers — MID ET, 2026-10-28

📊 MARKET MACRO: S&P 500 $771.39 +0.22% Nasdaq $722.29 +0.14% Dow $524.53 +0.24% Russell 2K $280.15 -0.01% VIX $17.33 -1.08% US Dollar $29.09 -0.09% Oil $169.19 +3.24% Gold $370.25 -0.55% Bitcoin $80,421.37 -0.47% Treasuries: 10Y 5% 30Y 5.31% Today's Fed / econ events: 18:30 [High] Press Conference 18:00 [High] Fed Interest Rate Decision 18:00 [High] FOMC Statement 15:00 [Medium] Atlanta Fed GDPNow (Q4) 14:30 [Medium] EIA Crude Oil Stocks Change (Oct/23) 14:30 [Medium] EIA Gasoline Stocks Change (Oct/23) 12:30 [Medium] Retail Inventories Ex Autos MoM (Sep) 12:30 [Medium] Wholesale Inventories MoM (Sep) 12:30 [High] Goods Trade Balance (Sep) 11:00 [Medium] MBA 30-Year Mortgage Rate (Oct/23)

🔥 HOT SECTORS TODAY (the sectors to watch): Healthcare +2.20% Basic Materials +0.39% Consumer Defensive +0.02% Energy -0.10%

📰 MARKET THEMES & CATALYSTS: • Stocks Are Calm, but There Is Real Volatility Hiding in Big Tech The VIX shows complacency. Other gauges don't. — barrons.com · 10/28 12:19p https://www.barrons.com/articles/big-tech-stocks-fed-rates-779c37c7 • Trump's Push to Fire Fed Governor Lisa Cook Looms Over Warsh Lisa D. Cook, a Fed governor, is set to face an unorthodox, private hearing over allegations of mortgage fraud she has consistently denied. — nytimes.com · 10/28 12:11p https://www.nytimes.com/2026/10/28/business/economy/trump-lisa-cook-warsh.html • How the Fed's Interest Rates Decision Affects Your Wallet The Federal Reserve is widely expected to leave its benchmark rate untouched, but a December hike could make holiday borrowing more costly. — nytimes.com · 10/28 12:03p https://www.nytimes.com/2026/10/28/business/economy/fed-interest-rates-credit-cards-loans.html • Trump's Revived Push to Fire a Fed Governor Looms Over Warsh. Lisa D. Cook, a Fed governor, is set to face an unorthodox, private hearing over allegations of mortgage fraud she has consistently denied. — nytimes.com · 10/28 12:00p https://www.nytimes.com/2026/10/28/business/economy/trumps-revived-push-to-fire-a-fed-governor-looms-over-warsh.html • Julian Emanuel: The earnings power of the AI revolution has further to run Julian Emanuel, Chief Equity and Quantitative Strategist at Evercore ISI, discusses AI's bull run, massive capital flows, credit market risks, Big Tech earnings, hyperscaler spending and Fed policy. — youtube.com · 10/28 11:45a https://www.youtube.com/watch?v=CNm1-2P1oTs

🐘 BIG-CAP MOVERS ON NEWS (≥$10B — the MRVL-class catalysts):

1. STLA +16% $4.80 (14B cap) Stellantis Surges 10% on Reaffirmed Guidance and Accelerating Cost Savings; Ford Inches Higher, General Motors and Tesla Hold Steady A confirmed 2026 outlook and a cost-cutting program that's gaining speed are sending Stellantis (NYSE:STLA | STLA Price Prediction) sharply higher, even as its Detroit rivals barely move. Stellantis stock sits at $4.57 early in the session, up 10%. — 247wallst.com · 10/28 10:04a https://247wallst.com/investing/2026/10/28/stellantis-surges-10-on-reaffirmed-guidance-and-accelerating-cost-savings-ford-inches-higher-general-motors-and-tesla-hold-steady/

2. SKHY +13% $164.32 (1166B cap) Chip Equipment Stocks Rally as SK Hynix Signals Memory Shortage Into 2030: Lam Research Jumps 5%, Applied Materials Climbs 4%, KLA Gains 3% Chip equipment stocks are leading a third straight day of gains across semiconductors as SK Hynix‘s (NASDAQ:SKHY) view that the memory shortage lasts into 2030 points to years of fab building. — 247wallst.com · 10/28 12:03p https://247wallst.com/investing/2026/10/28/chip-equipment-stocks-rally-as-sk-hynix-signals-memory-shortage-into-2030-lam-research-jumps-5-applied-materials-climbs-4-kla-gains-3/

3. SOXL +3% $104.40 (26B cap) (no fresh news today — likely technical / low-coverage move)

4. SOFI +3% $16.87 (22B cap) 2 Fintech Stocks to Buy While Their Customer Numbers Keep Climbing SoFi and Robinhood both look undervalued relative to their growth potential. — fool.com · 10/28 12:10p https://www.fool.com/investing/2026/10/28/2-fintech-stocks-to-buy-while-their-customer-numbe/

5. NOK +3% $9.12 (49B cap) Nokia: Stronger Optical And IP Outlook Makes The Pullback Attractive Nokia Oyj is rated Buy, driven by strong optical and IP network demand, new design wins, and manufacturing expansion. NOK guides for 25%-30% optical and IP network growth in 2027, with margin improvement from operating leverage and Infinera integration. Weaker near-term cash flo… — seekingalpha.com · 10/27 6:20p https://seekingalpha.com/article/4958220-nokia-stronger-optical-and-ip-outlook-makes-the-pullback-attractive

6. GRAB +2% $2.78 (11B cap) Grab (GRAB) Q3 Earnings on the Horizon: Analysts' Insights on Key Performance Measures Beyond analysts' top-and-bottom-line estimates for Grab (GRAB), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended September 2026. — zacks.com · 10/28 10:16a https://www.zacks.com/stock/news/3016904/grab-grab-q3-earnings-on-the-horizon-analysts-insights-on-key-performance-measures?cid=CS-STOCKNEWSAPI-FT-fundamental_analysis|nfm_preview-3016904

📈 TOP 8 GAINERS (small/mid-cap % leaders, with catalyst):

1. ULBI +146% $15.63 (260M cap) Ultralife Stock Soars 145%. EnerSys to Buy It for the ‘Battlefield of the Future. Ultralife stock soars as EnerSys prices in massive premium for a key cog in the ‘battlefield of the future.' — barrons.com · 10/28 9:56a https://www.barrons.com/articles/ultralife-stock-enersys-acquisition-c2b19d62

2. EVMN +35% $6.98 (255M cap) (no fresh news today — likely technical / low-coverage move)

3. GMAB +30% $57.92 (36B cap) Genmab Announces Statistically Significant, Clinically Meaningful Improvement in Overall Survival and Objective Response with Petosemtamab Combination at First Interim Analysis in First-Line R/M Patients with PD-L1+ Head and Neck Cancer Company Announcement COPENHAGEN, Denmark; October 28, 2026 Phase 3 LiGeR-HN1 trial of Petosemtamab in combination with pembrolizumab versus pembrolizumab alone met both primary endpoints, reducing the risk of death by 50% in patients with PD-L1 positive head and neck squamous ce… — globenewswire.com · 10/28 9:40a https://www.globenewswire.com/news-release/2026/10/28/3390308/0/en/genmab-announces-statistically-significant-clinically-meaningful-improvement-in-overall-survival-and-objective-response-with-petosemtamab-combination-at-first-interim-analysis-in-f.html

4. AXGN +28% $47.77 (2.8B cap) Axogen, Inc. (AXGN) Q3 2026 Earnings Call Transcript Axogen, Inc. (AXGN) Q3 2026 Earnings Call Transcript — seekingalpha.com · 10/28 12:09p https://seekingalpha.com/article/4958704-axogen-inc-axgn-q3-2026-earnings-call-transcript

5. KIDS +23% $29.38 (767M cap) OrthoPediatrics Corp. (KIDS) Q3 2026 Earnings Call Transcript OrthoPediatrics Corp. ( KIDS ) Q3 2026 Earnings Call October 27, 2026 4:30 PM EDT Company Participants David Bailey - President, CEO & Director Fred Hite - CFO, Principal Financial & Accounting Officer, COO and Director Conference Call Participants Philip Taylor - Gilmartin Grou… — seekingalpha.com · 10/28 12:00a https://seekingalpha.com/article/4958310-orthopediatrics-corp-kids-q3-2026-earnings-call-transcript

6. PRME +17% $5.08 (922M cap) (no fresh news today — likely technical / low-coverage move)

7. DNA +16% $13.09 (881M cap) (no fresh news today — likely technical / low-coverage move)

8. WEN +15% $7.06 (1.3B cap) There's an Offer on the Table for Wendy's at a ‘Crucial' Moment Squareburger maker Wendy's recently announced an $8 combo meal. It has a much bigger deal to contemplate today. — investopedia.com · 10/28 12:11p https://www.investopedia.com/there-s-an-offer-on-the-table-for-wendy-s-at-a-crucial-moment-wen-stock-trian-peltz-12198136

— auto-generated, alert-only (not investment advice). 'No fresh news' = likely a technical/low-float move, not a catalyst.